Pflug Koory’s Definium Therapeutics DFTX Stock Holding History

Pflug Koory’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35	Closed	-$1K	–	461
2022 Q1	$1K	Hold	35	–	–	﹤0.01%	450
2021 Q4	$1K	Hold	35	–	–	﹤0.01%	453
2021 Q3	$1K	Hold	35	–	–	﹤0.01%	450
2021 Q2	$2K	Buy	+35	New	+$1.84K	﹤0.01%	463

Other funds holding DFTX

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DCI

Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pflug Koory's DFTX Position: Q2 2022 in Review

Pflug Koory sold out of Definium Therapeutics (DFTX) in Q2 2022, closing a stake of 35 shares — an estimated $1K sold.

Pflug Koory first reported a position in DFTX in Q2 2021 and held it in 4 quarters. The position peaked at $2K in Q2 2021. 155 funds tracked by Wall St. Rank hold DFTX as of Q2 2022.

Pflug Koory reported no remaining Definium Therapeutics position as of Q2 2022 after selling out during the quarter.
Pflug Koory sold 35 Definium Therapeutics shares in Q2 2022, an estimated $1K.
Pflug Koory first reported a position in Definium Therapeutics in Q2 2021 and held it in 4 quarters.
Pflug Koory's Definium Therapeutics position peaked at $2K in Q2 2021.
155 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2022.

Based on Pflug Koory's 13F filing for Q2 2022, filed 1 Aug 2022.